MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
6906.58%
Quick Ratio
6906.58%
Cash Ratio
5372.19%
Debt to Asset Ratio
1.45%
Unit: Dollar
Assets Breakdown
Cash and cash equivalents
Short-term investments (note 4)
Receivables
Operating lease right-of-use ass...
Liabilities Breakdown
Common shares 44,388,550 issued ...
Accumulated deficit
Additional paid-in capital (note...
Accumulated other comprehensive ...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2025-06-30
Prepaids (note 5)
355,204
Short-term investments (note 4)
23,667,161
Receivables
527,148
Cash and cash equivalents
85,952,587
Total current assets
110,502,100
Operating lease right-of-use asset (note 7)
0
Total assets
110,502,100
Accounts payable and accrued liabilities (note 6)
1,599,955
Total current liabilities
1,599,955
Total liabilities
1,599,955
Accumulated deficit
-226,914,172
Common shares 44,388,550 issued and outstanding (september 30, 2024 - 44,388,550) (note 8)
279,862,420
Additional paid-in capital (note 8)
58,050,904
Accumulated other comprehensive loss
-2,097,007
Total stockholders equity
108,902,145
Total liabilities and shareholders' equity
110,502,100
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$85,952,587
Short-term investments
(note 4)
$23,667,161
Receivables
$527,148
Prepaids (note 5)
$355,204
Total current assets
$110,502,100
Total assets
$110,502,100
Total liabilities and
shareholders' equity
$110,502,100
Total stockholders
equity
$108,902,145
Total liabilities
$1,599,955
Accumulated deficit
-$226,914,172
Accumulated other
comprehensive loss
-$2,097,007
Common shares
44,388,550 issued and...
$279,862,420
Total current
liabilities
$1,599,955
Additional paid-in capital
(note 8)
$58,050,904
Accounts payable and
accrued liabilities...
$1,599,955
Buy us a coffee
ESSA Pharma Inc. (EPIX)
ESSA Pharma Inc. (EPIX)